Skip to main content Skip to footer
Circe
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact
Lund University

Endometrial cancer

Endometrial cancer develops in the lining of the uterus (endometrium) and is the most common type of uterine cancer. There are two main types: Endometrioid (Type 1) - most common, hormone-related and usually slower growing; and Non-endometrioid cancer (Type 2) – rare, more aggressive. Endometrial cancer often causes symptoms at an early stage, which increases the chances of early diagnosis.

Risk factors

The risk of endometrial cancer is associated with:

  • Increasing age, more common after menopause
  • Hormonal factors, prolonged exposure to estrogen
  • Overweight and obesity, which is a major risk factor
  • Reproductive history, such as not having had children
  • Early start of menstruation or late menopause
  • Polycystic ovary syndrome (PCOS)
  • Inherited genetic factors, such as Lynch syndrome

Some factors may lower risk, including use of combined hormonal contraceptives, hormone replacement therapy, and regular exercise.

Screening and early detection

There is no routine screening program for the general population. However, symptoms usually appear early.

Possible symptoms include:

  • Bleeding after menopause
  • Vaginal bleeding between periods
  • Abnormal discharge, especially after menopause

These symptoms are often caused by conditions other than cancer, such as fibroids, which are benign muscle tumors. However, they should always be evaluated by a doctor.

Diagnosis and treatment

If endometrial cancer is suspected, evaluation may include:

  • Gynecological examination
  • Ultrasound
  • Tissue sampling (biopsy)
  • Additional imaging to assess disease spread

Treatment depends on the stage and type of cancer, and may include:

  • Surgery, usually removal of the uterus (and often ovaries and fallopian tubes)
  • Radiotherapy
  • Chemotherapy
  • Hormone therapy in some cases

Living with and beyond endometrial cancer

Most people diagnosed with endometrial cancer have a good prognosis, but recovery varies.

Common effects of the disease or the treatment include:

  • Physical symptoms, such as fatigue
  • Emotional challenges, including anxiety or concerns about recurrence
  • Changes in daily life, including work and relationships

In Sweden healthcare-based support include:

  • A multidisciplinary care team for diagnosis, treatment, and follow-up
  • A contact nurse (kontaktsjuksköterska) who provides information and
  • coordinates care
  • Cancer rehabilitation services (Cancerrehabiliteringsmottagning) that support physical, emotional and social recovery

Fertility and family planning

Endometrial cancer mainly affects women after menopause, but it can also occur at younger ages.

Treatment often affects fertility:

  • Removal of the uterus makes pregnancy impossible
  • Removal of the ovaries may cause early menopause

In selected cases, it may be possible to consider fertility-preserving treatment may be possible. Fertility and reproductive health are part of cancer care, and patients can receive individual counselling to support informed decisions.

Reducing inequalities in endometrial cancer care

Although endometrial cancer is often diagnosed at an early stage, differences in awareness, risk factors, and access to healthcare can contribute to unequal outcomes.

Key factors include:

  • Awareness of symptoms, particularly postmenopausal bleeding, which is important for early diagnosis
  • Access to healthcare, including timely assessment, diagnosis, and treatment
  • Lifestyle-related risk factors, such as obesity, which is a major risk factor and is unevenly distributed across populations
  • Socioeconomic factors, including differences in income, education, and health literacy

These differences can influence when endometrial cancer is diagnosed and the care people receive. Improving awareness of symptoms and ensuring equitable access to healthcare are important for reducing inequalities and improving outcomes for all.

Key facts

  • In Sweden, over 1,500 women are diagnosed each year, making it one of the most common gynecological cancers
  • It mainly affects women after menopause
  • Most cases are detected early, leading to good outcomes
  • Is one of the most common gynecological cancers worldwide
  • Survival is generally high when detected early

Support and Resources

  • Cancerfonden

    Provides reliable information about endometrial cancer, including risk factors, symptoms, diagnosis, treatment, rehabilitation, and support.

  • 1177 Vårdguiden

    Sweden’s national healthcare information service, offering evidence-based information about endometrial cancer, symptoms, diagnosis, treatment, and available healthcare services.

  • Gyncancerförbundet

    Sweden’s national organization for people affected by gynecological cancers, offering information, peer support, local activities, and advocacy for patients and families.

  • Nätverket mot gynekologisk cancer

    A non-profit network that provides information about gynecological cancers and works to improve prevention, diagnosis, treatment, rehabilitation, and patient rights.

  • Patient.info – Endometrial Cancer

    Provides accessible information about endometrial cancer, including symptoms, diagnosis, treatment, fertility, and living with and beyond cancer.

CirceLund University
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact

Advancing women’s cancer research through collaboration, innovation, and equity

Founding grant support:

circecenter@med.lu.se

Tel: + 46 (0)46 222 0365

Lund University, CIRCE

Scheelevägen 2, MV-404-B2

223 81 Lund, Sweden

© 2026 CIRCEcenter.org. All rights reserved.
Designed by Clavis Communications